Enrique Codina Gibert
Amministratore Delegato presso Pharmacelera SL
Provenienza dei contatti di primo grado di Enrique Codina Gibert
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
Pharmacelera SL
 Pharmacelera SL Information Technology ServicesTechnology Services Pharmacelera SL engages in providing hardware and software solution services for pharm screen and pharmQSAR. Its products include pharmScreen, phramQSAP and phramaBox. The company was founded by Enric Herrero Abellanas and Enric Gibert Codina and is headquartered in Barcelona, Spain.
2
| Holding Company | Information Technology Services | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Enrique Codina Gibert tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Macrophage Pharma Ltd.
 Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Chief Executive Officer | |
| SANOFI | Pharmaceuticals: Major | Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Proteome Therapeutics, Inc.
 Advanced Proteome Therapeutics, Inc. BiotechnologyHealth Technology Part of Advanced Proteome Therapeutics Corp., Advanced Proteome Therapeutics Inc. is a company that has developed a proprietary approach for streamlining the production and targeted delivery of anti-cancer drugs to cancerous tumors. The company is based in Boston, MA. The company's work allows cancer drugs to be efficiently produced and delivered to cancerous tumors in a targeted fashion that doesn't destroy the patient's normal healthy cells indiscriminately. The benefit of targeted therapies, such as Advanced Proteome's approach, is their ability to home in on cancer cells while sparing healthy cells, thereby avoiding the nasty side effects of traditional chemotherapeutics. The CEO of the company is Benjamin Alexander Krantz. | Biotechnology | Chief Executive Officer | |
| GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
General Inception
 General Inception Investment ManagersFinance General Inception Management LLC (General Inception Management) is a venture capital firm founded in 2020 by Vikram Chaudhery, Paul A. Conley and Jim Buzzitta. The firm is headquartered in San Francisco, California. | Investment Managers | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Germania | 2 |
| Regno Unito | 2 |
| Francia | 2 |
| India | 2 |
Settori
| Health Technology | 6 |
| Consumer Services | 2 |
| Finance | 2 |
Posizioni
| Director/Board Member | 4 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Contatti più connessi
| Insiders | |
|---|---|
| Venkat Reddy | 9 |
| Abellanas Herrero | 1 |
- Borsa valori
- Insiders
- Enrique Codina Gibert
- Connessioni Società
